US Pharma MarketingThe post Labcorp’s advanced melanoma CDx secures FDA approval appeared first on Medical Device Network.
Labcorp’s advanced melanoma CDx secures FDA approval
Labcorp’s CDx is designed to detect BRAF V600E and V600K melanoma mutations to determine which patients are eligible for BRAF inhibitor regimens. The post Labcorp’s advanced melanoma CDx secures FDA approval appeared first on Medical Device Network .
Labcorp’s CDx is designed to detect BRAF V600E and V600K melanoma mutations to determine which patients are eligible for BRAF inhibitor regimens.
Source: Medical Device Network